BACKGROUND: Although sputum induction is used as a technique to investigate lower airway inflammation in asthmatic subjects, advantages over spontaneous sputum in patients with chronic obstructive pulmonary disease (COPD) have not been investigated. METHODS: Samples of spontaneous sputum and sputum induced with 3% hypertonic saline for 14 minutes were collected from 27 patients with chronic obstructive pulmonary disease (COPD) who usually produced spontaneous sputum. Spirometric indices and oxygen saturation (Sao2) were measured at seven minute intervals. The spontaneous, seven and 14 minute sputum samples were analysed for total and differential cell counts, cell viability, and interleukin 8 levels. RESULTS: Analysis of the sputum revealed that median cell viability was higher in the seven minute (62.8%; p = 0.004) and 14 minute (65%; p = 0.001) induced sputum samples than in spontaneous sputum (41.2%). There was no significant difference in total and differential cell counts or in interleukin 8 levels between spontaneous and induced sputum. During the sputum induction procedure the mean (SD) fall in forced expiratory volume in one second (FEV1) was 0.098 (0.111) 1 (p < 0.001) and in forced vital capacity (FVC) was 0.247 (0.233) 1 (p < 0.001). There was a small but significant fall in Sao2 during sputum induction (p = 0.03). CONCLUSIONS: Induced sputum contains a higher proportion of viable cells than spontaneous sputum. There are no significant differences between the sputum samples obtained at seven minutes and at 14 minutes of hypertonic saline nebulisation. Sputum induction is safe and well tolerated in patients with COPD.
BACKGROUND: Although sputum induction is used as a technique to investigate lower airway inflammation in asthmatic subjects, advantages over spontaneous sputum in patients with chronic obstructive pulmonary disease (COPD) have not been investigated. METHODS: Samples of spontaneous sputum and sputum induced with 3% hypertonicsaline for 14 minutes were collected from 27 patients with chronic obstructive pulmonary disease (COPD) who usually produced spontaneous sputum. Spirometric indices and oxygen saturation (Sao2) were measured at seven minute intervals. The spontaneous, seven and 14 minute sputum samples were analysed for total and differential cell counts, cell viability, and interleukin 8 levels. RESULTS: Analysis of the sputum revealed that median cell viability was higher in the seven minute (62.8%; p = 0.004) and 14 minute (65%; p = 0.001) induced sputum samples than in spontaneous sputum (41.2%). There was no significant difference in total and differential cell counts or in interleukin 8 levels between spontaneous and induced sputum. During the sputum induction procedure the mean (SD) fall in forced expiratory volume in one second (FEV1) was 0.098 (0.111) 1 (p < 0.001) and in forced vital capacity (FVC) was 0.247 (0.233) 1 (p < 0.001). There was a small but significant fall in Sao2 during sputum induction (p = 0.03). CONCLUSIONS: Induced sputum contains a higher proportion of viable cells than spontaneous sputum. There are no significant differences between the sputum samples obtained at seven minutes and at 14 minutes of hypertonicsaline nebulisation. Sputum induction is safe and well tolerated in patients with COPD.
Authors: E Pizzichini; M M Pizzichini; A Efthimiadis; S Evans; M M Morris; D Squillace; G J Gleich; J Dolovich; F E Hargreave Journal: Am J Respir Crit Care Med Date: 1996-08 Impact factor: 21.405
Authors: J Y Lacoste; J Bousquet; P Chanez; T Van Vyve; J Simony-Lafontaine; N Lequeu; P Vic; I Enander; P Godard; F B Michel Journal: J Allergy Clin Immunol Date: 1993-10 Impact factor: 10.793
Authors: M Linden; J B Rasmussen; E Piitulainen; A Tunek; M Larson; H Tegner; P Venge; L A Laitinen; R Brattsand Journal: Am Rev Respir Dis Date: 1993-11
Authors: Ashley G Henderson; Wayne H Anderson; Agathe Ceppe; Raymond D Coakley; Brian Button; Neil E Alexis; David B Peden; Eduardo R Lazarowski; C W Davis; Fred Fuller; Martha Almond; Bahjat Qaqish; Mehmet Kesimer; Richard C Boucher Journal: COPD Date: 2019-02-04 Impact factor: 2.409
Authors: Matthew R Markovetz; Durai B Subramani; William J Kissner; Cameron B Morrison; Ian C Garbarine; Andrew Ghio; Kathryn A Ramsey; Harendra Arora; Priya Kumar; David B Nix; Tadahiro Kumagai; Thomas M Krunkosky; Duncan C Krause; Giorgia Radicioni; Neil E Alexis; Mehmet Kesimer; Michael Tiemeyer; Richard C Boucher; Camille Ehre; David B Hill Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-08-07 Impact factor: 5.464
Authors: Geraint B Rogers; Stuart Skelton; David J Serisier; Christopher J van der Gast; Kenneth D Bruce Journal: J Clin Microbiol Date: 2009-11-11 Impact factor: 5.948
Authors: Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha Journal: Chest Date: 2009-10-16 Impact factor: 9.410